120 related articles for article (PubMed ID: 26238996)
1. Cancer care coordinators in stage III colon cancer: a cost-utility analysis.
Blakely T; Collinson L; Kvizhinadze G; Nair N; Foster R; Dennett E; Sarfati D
BMC Health Serv Res; 2015 Aug; 15():306. PubMed ID: 26238996
[TBL] [Abstract][Full Text] [Related]
2. Cancer Care Coordinators to Improve Tamoxifen Persistence in Breast Cancer: How Heterogeneity in Baseline Prognosis Impacts on Cost-Effectiveness.
Nair N; Kvizhinadze G; Blakely T
Value Health; 2016 Dec; 19(8):936-944. PubMed ID: 27987643
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
[TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer Screening: How Health Gains and Cost-Effectiveness Vary by Ethnic Group, the Impact on Health Inequalities, and the Optimal Age Range to Screen.
McLeod M; Kvizhinadze G; Boyd M; Barendregt J; Sarfati D; Wilson N; Blakely T
Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1391-1400. PubMed ID: 28626068
[No Abstract] [Full Text] [Related]
5. Exercise programmes to prevent falls among older adults: modelling health gain, cost-utility and equity impacts.
Deverall E; Kvizhinadze G; Pega F; Blakely T; Wilson N
Inj Prev; 2019 Aug; 25(4):258-263. PubMed ID: 29363590
[TBL] [Abstract][Full Text] [Related]
6. Home safety assessment and modification to reduce injurious falls in community-dwelling older adults: cost-utility and equity analysis.
Pega F; Kvizhinadze G; Blakely T; Atkinson J; Wilson N
Inj Prev; 2016 Dec; 22(6):420-426. PubMed ID: 27222247
[TBL] [Abstract][Full Text] [Related]
7. Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis.
McLeod M; Sandiford P; Kvizhinadze G; Bartholomew K; Crengle S
BMJ Open; 2020 Sep; 10(9):e037145. PubMed ID: 32973060
[TBL] [Abstract][Full Text] [Related]
8. The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects.
Nghiem N; Blakely T; Cobiac LJ; Cleghorn CL; Wilson N
BMC Public Health; 2016 May; 16():423. PubMed ID: 27216490
[TBL] [Abstract][Full Text] [Related]
9. Innovative chemotherapies for stage III colon cancer: a cost-effectiveness study.
Koperna T; Semmler D
Hepatogastroenterology; 2003; 50(54):1903-9. PubMed ID: 14696430
[TBL] [Abstract][Full Text] [Related]
10. Home modification to reduce falls at a health district level: Modeling health gain, health inequalities and health costs.
Wilson N; Kvizhinadze G; Pega F; Nair N; Blakely T
PLoS One; 2017; 12(9):e0184538. PubMed ID: 28910342
[TBL] [Abstract][Full Text] [Related]
11. Mass media promotion of a smartphone smoking cessation app: modelled health and cost-saving impacts.
Nghiem N; Leung W; Cleghorn C; Blakely T; Wilson N
BMC Public Health; 2019 Mar; 19(1):283. PubMed ID: 30849943
[TBL] [Abstract][Full Text] [Related]
12. Cataract surgery for falls prevention and improving vision: modelling the health gain, health system costs and cost-effectiveness in a high-income country.
Boyd M; Kvizhinadze G; Kho A; Wilson G; Wilson N
Inj Prev; 2020 Aug; 26(4):302-309. PubMed ID: 31221667
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand.
Lerdkiattikorn P; Chaikledkaew U; Lausoontornsiri W; Chindavijak S; Khuhaprema T; Tantai N; Teerawattananon Y
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):687-700. PubMed ID: 25327502
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women.
Lairson DR; Parikh RC; Cormier JN; Chan W; Du XL
Value Health; 2015 Dec; 18(8):1070-8. PubMed ID: 26686793
[TBL] [Abstract][Full Text] [Related]
15. Health, Health Inequality, and Cost Impacts of Annual Increases in Tobacco Tax: Multistate Life Table Modeling in New Zealand.
Blakely T; Cobiac LJ; Cleghorn CL; Pearson AL; van der Deen FS; Kvizhinadze G; Nghiem N; McLeod M; Wilson N
PLoS Med; 2015 Jul; 12(7):e1001856. PubMed ID: 26218517
[TBL] [Abstract][Full Text] [Related]
16. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.
Mullins CD; Hsiao FY; Onukwugha E; Pandya NB; Hanna N
Cancer; 2012 Jun; 118(12):3173-81. PubMed ID: 22020739
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation.
Hendriks J; Tomini F; van Asselt T; Crijns H; Vrijhoef H
Europace; 2013 Aug; 15(8):1128-35. PubMed ID: 23515338
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J
Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519
[TBL] [Abstract][Full Text] [Related]
19. Health and economic impacts of eight different dietary salt reduction interventions.
Nghiem N; Blakely T; Cobiac LJ; Pearson AL; Wilson N
PLoS One; 2015; 10(4):e0123915. PubMed ID: 25910259
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of single-fraction versus multiple-fraction palliative radiotherapy for painful bone metastases in breast, lung and prostate cancer.
Collinson L; Kvizhinadze G; Nair N; McLeod M; Blakely T
J Med Imaging Radiat Oncol; 2016 Oct; 60(5):650-660. PubMed ID: 27174870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
